Under construction – not a live service
Sign in
Taking people in DenmarkNo phase

Studying family health and needs during cancer care in Denmark

Surveys and interviews follow cancer patients and their caregivers over time.

Plain-language title generated from the registry record
Registry title: A Multi-center Investigation of Family Health.

Key facts

Where
Odense C, DenmarkSee the site

Where in Denmark

  • Odense University HospitalOdense C, DenmarkTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Odense University Hospital
Trial code
NCT06433349
Record updated
6 October 2025
Original description
The current healthcare system is unable to identify burdened and vulnerable families affected by cancer, partly due to a lack of knowledge of how cancer affects family health during treatment and survivorship. Recent reviews have documented a general lack of cancer studies including both the patient and the family, and a particular deficiency in studies including more than the spouse.Read full original descriptionShow less

A Multi-center Investigation of Family Health, Needs, Perceived Support, Self-efficacy and Quality of Life During the Cancer Trajectory: A Longitudinal Mixed Methods Study Among Danish Cancer Patients and Their Caregivers

The current healthcare system is unable to identify burdened and vulnerable families affected by cancer, partly due to a lack of knowledge of how cancer affects family health during treatment and survivorship. Recent reviews have documented a general lack of cancer studies including both the patient and the family, and a particular deficiency in studies including more than the spouse.

The principal aim of this study is to investigate family health, needs and perceived support, quality of life, self-efficacy, depression, stress and resilience in both patients with cancer and their families across the cancer trajectory. Additionally, the study seeks to identify particularly burdened and vulnerable families and investigate contributing factors to their vulnerability.

Inclusion: curative intended patients and their eventual appointed caregivers >18; breast-, prostate- colorectal cancer or lymphoma.

Exclusion: Not able to understand or give written informed consent; Not able to speak Danish or complete questionnaires in Danish.

ClinicalTrials.gov NCT06433349